VDR gene polymorphism in children with allergic diseases



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. To investigate the frequency of vitamin receptor gene D (VDR) polymorphism in children with allergic diseases. Materials and methods. We enrolled 130 children (66 boys and 64 girls) with allergic diseases aged from 1,5 to 16 years old. All children underwent clinical and allergological examination. 93 children (71,5%) had isolated allergy, mainly food allergy and atopic dermatitis, 37 children (28,4%) had bronchial asthma, associated with allergic rhinitis and urticaria. The control group included 41 healthy children aged from 1 to 10 years old. For DNA allotment the kit «ProbaRapid Genetics» of «DNA Technology» (Russia) was used. Analysis of polymorphic marker FokI (rs 2228570), BsmI (rs 1544410) and TaqI (rs 731236) of VDR gene was performed by PCR in real time using the detecting thermocycler DT-96, and kits for DNA diagnostics company «DNA technology» (Russia). Research metabolite 25-OH (25-hydroxyvitamin D2 and D3) of vitamin D was carried out by ELISA commercial kit «DIAsource» (Belgium). Results. Significantly increased frequency of allele A in the VDR gene BsmI site (OR=1,81, p=0,04) and homozygous A/A, heterozygous G/A genotype (OR=2,03, p=0,05 and OR=1,8, p=0,05, respectively) was found, that enables to consider it as a prognostic marker associated with the development of allergic disease risk. Statistically significant reduction in the concentration of 25-OH-vitamin D (p=0,02) in children with the heterozygous variant A/G and homozygous G/G in Fok1 VDR gene was found. Conclusion. There were significant differences in frequencies of genotypes and alleles of DVR gene in children with allergic diseases in the population. These results create the preconditions for the development of new methods of prevention of vitamin D deficiency, taking into account the individual characteristics of its metabolism.

Full Text

Restricted Access

About the authors

T B Sentsova

Scientific Research Institute of Nutrition

Author for correspondence.
Email: bio45@inbox.ru

I V Vorozhko

Scientific Research Institute of Nutrition

Email: bio45@inbox.ru

O O Chernyak

Scientific Research Institute of Nutrition

Email: bio45@inbox.ru

V A Revyakina

Scientific Research Institute of Nutrition

Email: bio45@inbox.ru

A M Timofeeva

Scientific Research Institute of Nutrition

Email: bio45@inbox.ru

V A Mukhortyh

Scientific Research Institute of Nutrition

Email: bio45@inbox.ru

A E Donnikov

Scientific Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov

Email: bio45@inbox.ru

References

  1. Дедов И.И., Тюльпаков А.Н., Чехонин В.П. и соавт. Персонализированная медицина: современное состояние и перспективы. Вестн. РАМН. 2012, № 12, с. 4-12.
  2. Ortiz R.A., Barnes K.C. Genetics of allergic diseases. Immunol. Allergy Clin. North Am. 2015, v. 35, p. 19-44.
  3. Yucesoy B., Kashon V.L., Johnson V.J. et al. Genetic variants in TNFa, TGFB1, PTGS1 and PTGS2 genes are associated with disocyanate-induced asthma. J. Immunotoxicol. 2015, v. 27, p. 1-8.
  4. Фрейдин М.Б., Пузырёв В.П. Синтропные гены аллергических заболеваний. Генетика. 2010, № 2, с. 255-261.
  5. Saccone D., Asani F., Bornman L. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene. 2015, v. 561, p. 171-180.
  6. Gruber B.M. The phenomen of vitamin D. Postery Hig Med. Dosw. 2015, v. 69, p. 127-139.
  7. Bunyavanich S., Schadt E.E. Systems biology of asthma and allergic diseases: a multiscale approach. J. Allergy Clin. Immunol. 2015, v. 135, p. 31-42.
  8. Barry E.L., Rees J.R., Peacock J.L. et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J. Clin. Endocrinol. Metab. 2014, v. 99, p. 133-137.
  9. Gnagnarella P., Pasquali E., Serrano D. et al. Vitamin D polimorphism and cancer risk: a comprehensive meta-analysis. Carcinogenesis. 2014, v. 35, p. 1913-1919.
  10. Taiouri L., Ovcaric M., Curtain R. et al.Vaariation in the vitamin D receptor gene is associated with multiple sclerosis in Australian population. J. Neurogenet. 2005, v. 19, p. 25-38.
  11. Liu Z., Liu L., Chen X. et al. Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complication: a meta-analysis. Gene. 2014, v. 546, p. 6-10.
  12. Wobke T.K., Sorg B.L., Steinhiber D. Vitamin D in inflammatory diseases. Front Physiol. 2014, v. 5, p. 244-256.
  13. Миронова Ж.А. Молекулярно-генетические аспекты терапевтической резистентности у больных бронхиальной астмой. Автореферат диссертации д-ра мед. наук. СПб., 2012, 24 с.
  14. Heine G., Hoefer N., Franke A. et al. Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br. J. Dermatol. 2013, v. 168, p. 855-858.
  15. Levin G.P., Robinson-Cohen C., de Boeret Ian H. et al. Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes. Vitamin D Concentrations and Clinical Outcomes. JAMA. The Journal of the American Medical Association. 2012, v. 308, р. 1898-1905.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2016



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies